| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |